# VACCINE AND TREATMENT EVALUATION UNITS (VTEU): PROTOCOL DEVELOPMENT AND IMPLEMENTATION, FOR A PHASE 1 ANTHRAX VACCINE TRIAL

> **NIH NIH N01** · UNIVERSITY OF MARYLAND BALTIMORE · 2022 · $23,948

## Abstract

This program is comprised of a consortium of individual contracts within academic centers and organizations that provide a ready resource for the design and conduct of clinical trials to evaluate promising products to combat infectious diseases. In general, products will be evaluated in normal healthy populations; however, access to special populations  is also available.

## Key facts

- **NIH application ID:** 10597508
- **Project number:** 272201300022I-P00004-759301900132-1
- **Recipient organization:** UNIVERSITY OF MARYLAND BALTIMORE
- **Principal Investigator:** KAREN KOTLOFF
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $23,948
- **Award type:** —
- **Project period:** 2019-06-05 → 2024-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10597508

## Citation

> US National Institutes of Health, RePORTER application 10597508, VACCINE AND TREATMENT EVALUATION UNITS (VTEU): PROTOCOL DEVELOPMENT AND IMPLEMENTATION, FOR A PHASE 1 ANTHRAX VACCINE TRIAL (272201300022I-P00004-759301900132-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10597508. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*